Evidence map›Paper›PMID 24712462›Full record

ReviewImmunological reviews2014

The importance of regulatory T-cell heterogeneity in maintaining self-tolerance.

Xiaomei Yuan, Guoyan Cheng, Thomas R Malek

Abstract readReview
In one paragraph

Review in Immunological reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Memory regulatory T cells in pregnancy.Frontiers in immunology · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. FOXP3 exon 2 controls TScience immunology · 2022
    Article
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaomei YuanDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL, USA.
Guoyan Cheng
Thomas R Malek

Funding

The immunobiology of CD4+ CD25+ T regulatory cellsR01AI055815 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MALEK, THOMAS R · 2004 to 2015
$3.5M
IL-2-dependent mechanisms in T1DR01DK093866 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MALEK, THOMAS R · 2012 to 2015
$1.3M
NIAID NIH HHS R01 AI055815NIDDK NIH HHS R01 DK093866
6 · The paper itself

Abstract

CD4(+) Forkhead box protein 3 (Foxp3)(+) regulatory T cells (Tregs) are the major cell type that mediates dominant tolerance in the periphery. Over the past decade, extensive study of Tregs has revealed that these cells express substantial heterogeneity to maintain tolerance and regulate immune responses. Tregs possess heterogeneity with respect to their origin and processes for development, functional activity, migratory pattern, and activation status. Some of the same environmental cues and molecular pathways utilized to generate specialized T-effector cells are also integrated by Tregs to colocalize and fine-tune suppressive mechanisms to optimally regulate and restrain distinctive self and antigen-specific T-cell responses. Here, we review our current understanding and significance of Treg heterogeneity in maintaining peripheral immune tolerance. We also highlight recent work from our laboratory that has studied the extent phenotypically distinct Treg subsets are related to each other and expand in an ordered fashion to give rise to highly activated short-lived Klrg1(+) suppressor cells to optimize immune regulation and maintain homeostasis of the Treg compartment.

Indexed as

AnimalsCell DifferentiationCell MovementGene ExpressionHumansImmunologic MemoryPhenotypeReceptors, ImmunologicSelf ToleranceT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsReceptors, ImmunologiceffectorKlrg1memorysubsetstoleranceTregs

Identifiers

PMID24712462
PMCPMC3983566

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.